Full Name
Jean Paul Thiery
(not current staff)
Variants
Thiery, J.
Thiery, J.P.
Thiery, Jean Paul
Thiery, J.-P.
Thiery J.P.
 
Main Affiliation
 
 
Email
bchtjp@nus.edu.sg
 

Publications

Results 41-60 of 70 (Search time: 0.014 seconds).

Issue DateTitleAuthor(s)
412016Identification of 42 genes linked to stage II colorectal cancer metastatic relapseAl-Temaimi, R.A; Tan, T.Z ; Marafie, M.J; Thiery, J.P ; Quirke, P; Al-Mulla, F
2Jun-2013Loss of Git2 induces epithelial-mesenchymal transition by miR146a-Cnot6L-controlled expression of Zeb1Zhou, W.; Thiery, J.P. 
320-Aug-2016Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast CarcinomaLoo, Ser Yue ; Hirpara, Jayshree L ; Pandey, Vijay ; Tan, Tuan Zea ; Yap, Celestial T ; Lobie, Peter E ; Thiery, Jean Paul ; Goh, Boon Cher ; Pervaiz, Shazib ; Clement, Marie-Veronique ; Kumar, Alan Prem 
41-Jul-2015MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaKong, Li Ren ; Chua, Kian Ngiap ; Sim, Wen Jing ; Ng, Hsien Chun ; Bi, Chonglei; Ho, Jingshan ; Nga, Min En ; Pang, Yin Huei ; Ong, Weijie Richard; Soo, Ross Andrew ; Huynh, The Hung ; Chng, Wee Joo ; Thiery, Jean-Paul ; Goh, Boon Cher 
5Sep-2011Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumorToh, B.; Wang, X.; Keeble, J.; Sim, W.J.; Khoo, K.; Wong, W.-C.; Kato, M.; Prevost-Blondel, A.; Thiery, J.-P. ; Abastado, J.-P.
615-Jan-2014Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinomaTang, Z.; Ow, G.S.; Thiery, J.P. ; Ivshina, A.V.; Kuznetsov, V.A.
721-Feb-2013Microfluidic cell trap array for controlled positioning of single cells on adhesive micropatternsLin, L.; Chu, Y.-S.; Thiery, J.P. ; Lim, C.T. ; Rodriguez, I.
82017Molecular characterization of breast cancer CTCs associated with brain metastasisBoral, D; Vishnoi, M; Liu, H.N; Yin, W; Sprouse, M.L; Scamardo, A; Hong, D.S; Tan, T.Z ; Thiery, J.P ; Chang, J.C; Marchetti, D
92016Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrinAbu-Tayeh, H; Weidenfeld, K; Zhilin-Roth, A; Schif-Zuck, S; Thaler, S; Cotarelo, C; Tan, T.Z ; Thiery, J.P ; Green, J.E; Klorin, G; Sabo, E; Sleeman, J.P; Tzukerman, M; Barkan, D
102015Pentimento: Neural Crest and the origin of mesectodermWeston J.A.; Thiery, Jean Paul 
112019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
122-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
13Mar-2014Raf kinase inhibitory protein role in the molecular subtyping of breast cancerAl-Mulla, F.; Marafie, M.; Tan, T.Z.; Thiery, J.P. 
142014Rapid prototyping of concave microwells for the formation of 3D multicellular cancer aggregates for drug screeningTu, T.-Y.; Wang, Z.; Bai, J.; Sun, W.; Peng, W.K.; Huang, R.Y.-J.; Thiery, J.-P. ; Kamm, R.D.
151-Oct-2013Remarkable disparity in mechanical response among the extracellular domains of type i and II cadherinsLiu, R. ; Wu, F.; Thiery, J.P. 
16Feb-2013Screening therapeutic EMT blocking agents in a three-dimensional microenvironmentAref, A.R.; Huang, R.Y.-J.; Yu, W.; Chua, K.-N.; Sun, W.; Tu, T.-Y.; Bai, J.; Sim, W.-J.; Zervantonakis, I.K.; Thiery, J.P. ; Kamm, R.D.
1715-Dec-2023SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibitionLai, Xianning ; Lui, Sarah Kit Leng ; Lam, Hiu Yan ; Adachi, Yuta; Sim, Wen Jing ; Vasilevski, Natali; Armstrong, Nicola J; Bridgeman, Stephanie Claire; Main, Nathan Michael; Tan, Tuan Zea ; Tirnitz-Parker, Janina EE; Thiery, Jean Paul ; Ebi, Hiromichi; Kumar, Alan Prem ; Eichhorn, Pieter Johan Adam 
182019SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transitionSundararajan, V. ; Tan, M.; Tan, T.Z. ; Ye, J. ; Thiery, J.P. ; Huang, R.Y.-J. 
192014SPHK1 regulates proliferation and survival responses in triplenegative breast cancerDatta, A ; Loo, S.Y ; Huang, B ; Wong, L ; Tan, S.S.L ; Tan, T.Z ; Lee, S.-C ; Thiery, J.P ; Lim, Y.C ; Yong, W.P ; Lam, Y ; Kumar, A.P ; Yap, C.T 
2018-Jul-2011Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition conceptChua, K.-N.; Poon, K.L.; Lim, J.; Sim, W.-J.; Huang, R.Y.J.; Thiery, J.P.